• Something wrong with this record ?

Implementation of Mass Cytometry for Immunoprofiling of Patients with Solid Tumors

I. Poláková, O. Pelák, D. Thürner, B. Pokrývková, R. Tachezy, T. Kalina, M. Šmahel,

. 2019 ; 2019 (-) : 6705949. [pub] 20190211

Language English Country Egypt

Document type Journal Article

Monitoring immune responses to solid cancers may be a better prognostic tool than conventional staging criteria, and it can also serve as an important criterion for the selection of individualized therapy. Multiparametric phenotyping by mass cytometry extended possibilities for immunoprofiling. However, careful optimization of each step of such method is necessary for obtaining reliable results. Also, with respect to procedure length and costs, sample preparation, staining, and storage should be optimized. Here, we designed a panel of 31 antibodies which allows for identification of several subpopulations of lymphoid and myeloid cells in a solid tumor and peripheral blood simultaneously. For sample preparation, disaggregation of tumor tissue with two different collagenases combined with DNase I was compared, and removal of dead or tumor cells by magnetic separation was evaluated. Two possible procedures of barcoding for single-tube staining of several samples were examined. While the palladium-based barcoding affected the stability of several antigens, the staining with two differently labeled CD45 antibodies was suitable for cells isolated from a patient's blood and tumor. The storage of samples in the intercalation solution for up to two weeks did not influence results of the analysis, which allowed the measurement of samples collected within this interval on the same day. This procedure optimized on samples from patients with head and neck squamous cell carcinoma enabled identification of various immune cells including rare subpopulations.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19027708
003      
CZ-PrNML
005      
20190823125924.0
007      
ta
008      
190813s2019 ua f 000 0|eng||
009      
AR
024    7_
$a 10.1155/2019/6705949 $2 doi
035    __
$a (PubMed)30886872
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ua
100    1_
$a Poláková, Ingrid $u Department of Genetics and Microbiology, Faculty of Science, Charles University, BIOCEV, Průmyslová 595, 25250 Vestec, Czech Republic.
245    10
$a Implementation of Mass Cytometry for Immunoprofiling of Patients with Solid Tumors / $c I. Poláková, O. Pelák, D. Thürner, B. Pokrývková, R. Tachezy, T. Kalina, M. Šmahel,
520    9_
$a Monitoring immune responses to solid cancers may be a better prognostic tool than conventional staging criteria, and it can also serve as an important criterion for the selection of individualized therapy. Multiparametric phenotyping by mass cytometry extended possibilities for immunoprofiling. However, careful optimization of each step of such method is necessary for obtaining reliable results. Also, with respect to procedure length and costs, sample preparation, staining, and storage should be optimized. Here, we designed a panel of 31 antibodies which allows for identification of several subpopulations of lymphoid and myeloid cells in a solid tumor and peripheral blood simultaneously. For sample preparation, disaggregation of tumor tissue with two different collagenases combined with DNase I was compared, and removal of dead or tumor cells by magnetic separation was evaluated. Two possible procedures of barcoding for single-tube staining of several samples were examined. While the palladium-based barcoding affected the stability of several antigens, the staining with two differently labeled CD45 antibodies was suitable for cells isolated from a patient's blood and tumor. The storage of samples in the intercalation solution for up to two weeks did not influence results of the analysis, which allowed the measurement of samples collected within this interval on the same day. This procedure optimized on samples from patients with head and neck squamous cell carcinoma enabled identification of various immune cells including rare subpopulations.
650    _2
$a monoklonální protilátky $x metabolismus $7 D000911
650    _2
$a separace buněk $7 D002469
650    _2
$a kolagenasy $x metabolismus $7 D017364
650    _2
$a taxonomické DNA čárové kódování $7 D058893
650    _2
$a deoxyribonukleasa I $x metabolismus $7 D003850
650    _2
$a průtoková cytometrie $7 D005434
650    _2
$a lidé $7 D006801
650    _2
$a imunofenotypizace $x metody $7 D016130
650    _2
$a antigeny CD45 $x imunologie $7 D017493
650    _2
$a lymfocyty $x fyziologie $7 D008214
650    _2
$a myeloidní buňky $x fyziologie $7 D022423
650    _2
$a nádory $x diagnóza $x imunologie $7 D009369
650    _2
$a palladium $x metabolismus $7 D010165
650    _2
$a analýza jednotlivých buněk $7 D059010
655    _2
$a časopisecké články $7 D016428
700    1_
$a Pelák, Ondřej $u CLIP-Childhood Leukaemia Investigation Prague, Department of Paediatric Haematology and Oncology, Second Faculty of Medicine, Charles University and Motol University Hospital, V Úvalu 84, 15006 Prague 5, Czech Republic.
700    1_
$a Thürner, Daniel $u CLIP-Childhood Leukaemia Investigation Prague, Department of Paediatric Haematology and Oncology, Second Faculty of Medicine, Charles University and Motol University Hospital, V Úvalu 84, 15006 Prague 5, Czech Republic.
700    1_
$a Pokrývková, Barbora $u Department of Genetics and Microbiology, Faculty of Science, Charles University, BIOCEV, Průmyslová 595, 25250 Vestec, Czech Republic.
700    1_
$a Tachezy, Ruth $u Department of Genetics and Microbiology, Faculty of Science, Charles University, BIOCEV, Průmyslová 595, 25250 Vestec, Czech Republic.
700    1_
$a Kalina, Tomáš $u CLIP-Childhood Leukaemia Investigation Prague, Department of Paediatric Haematology and Oncology, Second Faculty of Medicine, Charles University and Motol University Hospital, V Úvalu 84, 15006 Prague 5, Czech Republic.
700    1_
$a Šmahel, Michal $u Department of Genetics and Microbiology, Faculty of Science, Charles University, BIOCEV, Průmyslová 595, 25250 Vestec, Czech Republic.
773    0_
$w MED00186351 $t Journal of immunology research $x 2314-7156 $g Roč. 2019, č. - (2019), s. 6705949
856    41
$u https://pubmed.ncbi.nlm.nih.gov/30886872 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20190813 $b ABA008
991    __
$a 20190823130138 $b ABA008
999    __
$a ok $b bmc $g 1432857 $s 1066168
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 2019 $c - $d 6705949 $e 20190211 $i 2314-7156 $m Journal of immunology research $n J. immunol. res. $x MED00186351
LZP    __
$a Pubmed-20190813

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...